Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC) will look for acquisitions. During the company's investors conference call, Andrea Recordati, Chief Executive Officer said "with the diverse and well-balanced portfolio, SPC offers a very solid and diversified platform with single-digit growth but can be leveraged with accretive business development deals that complement our capabilities and footprint just by the recent one with Eligard. Hence, our continued focus on inorganic acquisitions or new licenses to accelerate growth and sustain margins of this part of the business". Andrea Recordati added, "Starting with SPC, we will continue to look actively for licensing and acquisition opportunities, and we will continue to pursue the right mix of the innovation immediately accretive mature assets with turnaround potential and OTC brands. Also, we will continue to invest preferably in our commercial or near-to-market opportunities. We do not plan to further expand our geographical region for short term, but we would position ourselves as a regional partner for leveraging on our commercial platform and proven integration capabilities".